Evelyn joined InflaRx in 2017 as Head of Clinical Operations.
She started her career at an international CRO before moving to pharmaceutical industry. Evelyn held different positions within Clinical Operations in small sized biotech companies and international big pharma companies, focusing on the development of monoclonal antibodies and small molecules in autoimmune diseases, rare diseases and cancer.
Bringing in over 15 years of experience in clinical project management and people management, Evelyn built and leads at InflaRx a strong Clinical Operations team and oversees the global Clinical Operations activities.
Evelyn holds a Ph.D. in Immunology from the University of Freiburg and the Max Planck Institute of Immunobiology.